The 2026 American Academy of Dermatology (AAD) Annual Meeting brings together dermatology professionals from around the world to explore the latest scientific advances, clinical insights, and emerging approaches shaping the field.

During the meeting, Nick Reder, CEO of Alpenglow Biosciences, will be available for a limited number of selected 1:1 discussions with research and industry leaders interested in the future of tissue-scale analysis in dermatology.

These conversations focus on how quantitative 3D tissue imaging and spatial analysis are enabling deeper biological insight from intact tissue, supporting translational research and informing development decisions beyond what traditional 2D pathology can capture.

Request a meeting to reserve a time during AAD.